Stay updated on Nivolumab Tailored RT & Cisplatin in Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Tailored RT & Cisplatin in Cervical Cancer Clinical Trial page.

Latest updates to the Nivolumab Tailored RT & Cisplatin in Cervical Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded a Locations section with Rhode Island as a study site and replaced the Rhode Island Locations heading. The page revision is updated to v3.3.3.SummaryDifference0.2%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedRevision: v3.3.2 was added and v3.2.0 removed; there are no visible changes to the study details, eligibility criteria, or page layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedThe government funding/operational status banner was removed, while core study details remain unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check66 days agoChange DetectedThe update consists of timestamp changes (such as the Last Update posted date) with no changes to the study design, eligibility criteria, or treatment information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check95 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference4%

- Check102 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Tailored RT & Cisplatin in Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Tailored RT & Cisplatin in Cervical Cancer Clinical Trial page.